Oppenheimer raises Pharvaris stock price target on trial results

Story context

What to watch: Target Corp. (TGT) had its price target revised — a single analyst move is a data point, not a thesis on its own.

Latest session change: $TGT -1.05%

Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures come from the published headline or preview. Session moves may include other news and do not establish cause.